Status:
COMPLETED
Neural Changes in the Aging Auditory System
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Rochester Institute of Technology
National Institute on Aging (NIA)
Conditions:
Progesterone
Estrogens
Eligibility:
FEMALE
60-86 years
Brief Summary
The purpose of this study was to determine the effects of hormone replacement therapy (HRT) on hearing in post-menopausal women.
Detailed Description
Background: Female hormone influences on the development and aging of the auditory system are not completely understood. The present study retrospectively analyzed and compared hearing abilities among...
Eligibility Criteria
Inclusion
- Healthy middle ears
Exclusion
- ototoxic medications
- serious medical health problems
- neurological conditions
- Meniere's disease or labyrinthitis
- those who failed cognitive screening tests (Mini-Mental Test)
- current/heavy smokers
- conductive hearing loss
- history of noise damage and/or audiograms signifying noise damage
- poor speech discrimination scores (80% or less)
Key Trial Info
Start Date :
January 1 2001
Trial Type :
OBSERVATIONAL
End Date :
February 1 2005
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00264407
Start Date
January 1 2001
End Date
February 1 2005
Last Update
December 12 2005
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
International Center Hearing & Speech Research - NTID - RIT
Rochester, New York, United States, 14623-5604
2
University of Rochester Medical Center
Rochester, New York, United States, 14642